Matching slides 41,117
Current window 25,141-25,170
Pages 1,371
Rows per page 30
Component: Disclaimerclear collectionreset all

Component

25,141-25,170 of 41,117

filter-aware
23
Includes footnotes detailing specific fund obligations and accounting treatments for performance fees.Apollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
25
Includes footnotes explaining the calculation methodology for distributable earnings and per-share metrics.Apollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
26
The table includes footnotes regarding fund inclusion criteria and performance metrics (NM = Not Meaningful).Apollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
27
The slide is a continuation of a financial disclosure table, focusing on Credit and Real Assets performance metrics.Apollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
29
Includes footnotes 1-4 detailing specific adjustments.Apollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
30
This is a standard financial disclosure slide typically found in an earnings presentation appendix.Apollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
37
Apollo Global Management | Results Presentation Deck | 37 slidesApollo Global Management | Results Presentation Deck | 37 slides · Apollo Global Management
Press release Investor relations Loop · Golden Circle1 hit
04
Includes a disclaimer footnote regarding financial data and APMs.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Humble Origins1 hit
06
The slide uses a consistent color scheme where dark green represents 2021, teal represents 2020, and grey represents 2019.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Early Struggles1 hit
07
Includes a donut chart for model breakdown, a map for regional growth, and bar charts for ASP and regional volume.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Early Struggles1 hit
08
The chart illustrates the revenue growth components: Sale of vehicles, Sale of parts, Servicing of vehicles, and Brand & motorsport.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Early Struggles1 hit
09
The slide uses a waterfall chart to bridge the gap between 2020 and 2021 EBITDA, followed by a detailed EBT reconciliation table.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
10
The chart shows the reconciliation of EBT to Free Cash Flow, highlighting key drivers like D&A, Working Capital, and Investing Activities.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
14
The slide uses a six-column layout to categorize operational and strategic progress.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising Success1 hit
02
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
10
The slide uses a standard clinical trial flow diagram (CONSORT-style).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
11
The slide demonstrates that the two study arms are well-balanced at baseline, which is a standard requirement for clinical trial validity.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a forest plot to visualize HRs and 95% CIs for multiple clinical subgroups.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
The slide highlights specific safety metrics including AE grades, death, and treatment modifications.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
27
The slide presents two distinct clinical data sets: a summary table for the BAYOU trial and a spider plot for the U105 trial.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a three-column layout to categorize performance metrics and operational highlights.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
07
The slide presents two side-by-side tables comparing FY 2021 and Q4 2021 performance metrics.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
10
The slide uses a table format to categorize pipeline progress by regulatory status and geography.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
12
Includes footnotes regarding CER (constant exchange rates) and expense definitions.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Includes footnotes regarding CER (constant exchange rates), R&D, SG&A, and percentage points.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide uses stacked bar charts to visualize revenue growth by region (US, Europe, ERoW, EM) for two key products.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Includes a stacked bar chart for product sales, a list of regional growth drivers, and a stacked bar chart for collaboration revenue.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Includes product imagery and detailed footnotes for medical abbreviations.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit